Research grants to study gut bacteria, IBD, IBS and the microbiome awarded to U of Calgary March 31, 2016

A unique set of grants focused on patient-oriented research were announced today. Patients and their families were involved in the research process and were able to formulate the types of questions they want scientists to answer about the diseases that affect them.

Minister of Health Jane Philpott announced the funding of five new research networks through Canada’s Strategy for Patient-Oriented Research (SPOR) at an event held at McMaster University in Hamilton, Ont. The University of Calgary is co-leading two of the initiatives focused on gastrointestinal disease and kidney disease.

The gastrointestinal disease component is a national collaboration of patients and scientists that will look at how gut bacteria and diet cause IBD, irritable bowel syndrome (IBS) and the anxiety and depression associated with these disorders.

There is a basic science component to the project that involves the microbiome centre at the University of Calgary where researchers will work to understand gut bacteria in the bowel.

Click here to read more.

 

Learn to Manage Your Fibromyalgia

There are 2 workshops/seminars taking place concurrently in Cambridge and Kitchener.

Kitchener – Learn to Manage Your Fibromyalgia

When: Every Monday at 1:00 – 3:30
from April 11, 2016 to May 16, 2016

Cost: Free, but registration is required.

Contact: 519-783-0020 ext. 3106

Email: event.registration@family-medicine.ca

Website: http://family-medicine.ca/event/learn-to-manage-your-fibromyalgia/

Poster: http://family-medicine.ca/images/Fibromyalgia-poster-2016.pdf

 

Cambridge – Learn to Manage Your Fibromyalgia

When: Every Monday at 1:00 – 3:30
from April 11, 2016 to May 16, 2016

Cost: Free, but registration is required.

Contact: Lynda 519-653-1470 ext. 383

Poster (pdf): https://drive.google.com/open?id=0B6b9flSfQK81SmFtZlRJOGN5UTA

Family physician helps patients with chronic pain

“… with all of my patients with chronic pain, in addition to providing referrals, investigations, specialist consults, and medication changes and renewals; I can offer education and self-management resources. I negotiate with patients the agenda to discuss self-management during regular monthly follow-up appointments which is important for pharmaco-vigilance and encouraging a systematic comprehensive approach to care.”

Read more here:
http://thischangedmypractice.com/chronic-pain-resource/

People in Pain Network Pain ToolKit

Offers two Pain ToolKits:
http://www.pipain.com/pain-toolkits.html

Adult Pain ToolKit

Developed to help adults to manage the daily challenges faced for people living with persistent pain:
http://www.paintoolkit.org/downloads/Pain_Toolkit_Canada.pdf

Youth Pain ToolKit

Developed to help youth people to manage the daily challenges faced for people living with persistent pain:
http://www.paintoolkit.org/downloads/Pain_Toolkit_for_Teenagers_Canada_Jan_2014_%281%29.pdf

Low Back Pain: CORE Back Tool

The Centre for Effective Practice (CEP) has created the following:
http://effectivepractice.org/resources/low-back-pain-tools/
as part of the Provincial Low Back Pain Project.

You will find many tools on their site, including the ones below.

As part of the Excellent Care for All Strategy, the Ministry of Health and Long Term Care (MOHLTC) has funded a provincial initiative on Low Back Pain which aims to enhance patient care, improve wait times and reduce inappropriate diagnostic utilization. Education tools have been developed to assist primary care providers in better managing patients with low back pain.

LOW BACK PAIN PATIENT SELF-MANAGEMENT VIDEO:

The Centre for Effective Practice is excited to release a new patient video on Low Back Pain created by Dr. Mike Evans (Health Design Lab) and developed in collaboration with the Government of Ontario, and the Institute for Work & Health.

The video is targeted at Ontario adults who may be experiencing an episode of low back pain and is based on existing primary care provider evidence-informed standardized clinical tools and resources previously developed as part of the provincial Strategy.

 

For Patients:

 

Centre for Effective Practice (CEP) is a national not-for-profit organization that is funded through its project work with organizations that have a shared vision for improving the quality of care for Canadians.

What is Cannabis (Marijuana, Hashish)

Street names: marijuana (grass, weed, pot, dope, ganja and others), hashish (hash), hash oil (weed oil, honey oil)

Cannabis sativa, also known as the hemp plant, has been cultivated for centuries for industrial and medical use, and for its “psychoactive,” or mind-altering, effects. Marijuana, hashish and hashish oil all derive from the cannabis plant.

More than 61 chemicals, called cannabinoids, have been identified as specific to the cannabis plant. THC (delta-9-tetrahydrocannabinol) is the main psychoactive cannabinoid, and is most responsible for the “high” associated with marijuana use.

Click here to read more from the CAMH website.

What are opioids?

Street names: M, morph, (for morphine); meth (for methadone); percs (for Percodan, Percocet); juice (for Dilaudid); oxy, OC, hillbilly heroin (for OxyContin).

Opioids are a family of drugs that have morphine-like effects. The primary medical use for prescription opioids is to relieve pain. Other medical uses include control of coughs and diarrhea, and the treatment of addiction to other opioids. Opioids can also produce euphoria, making them prone to abuse. Some people use opioids for their ability to produce a mellow, relaxed “high.”

Federal laws regulate the possession and distribution of all opioids. Use of prescription opioids is legal only when they are prescribed by a licensed medical practitioner, and are used by the person to whom they are prescribed. Illegal use includes “double doctoring,” or obtaining a prescription from more than one doctor without telling the prescribing doctor about other prescriptions received in the past 30 days. Penalties for the illegal possession and distribution of prescription opioids include fines, imprisonment or both.

Where do opioids come from?

Some opioids, such as morphine and codeine, occur naturally in opium, a gummy substance collected from the seed pod of the opium poppy, which grows in southern Asia. Semi-synthetic opioids, such as oxycodone (e.g., OxyContin), hydromorphone (e.g., Dilaudid) or hydrocodone (e.g., Tussionex) are made by changing the chemical structure of naturally occurring opioids. Synthetic opioids, such as methadone, meperidine (e.g., Demerol) and fentanyl (Duragesic Patch), are made from chemicals without using a naturally occurring opioid as a starting material.

Click here to read more from the CAMH website.

Canadian Consortium for the Investigation of Cannabinoids

The purpose of the Canadian Consortium for the Investigation of Cannabinoids (CCIC) is to advance our understanding of the role of cannabinoids in health and disease through research and education.

The CCIC is a federally registered Canadian nonprofit organization of basic and clinical researchers and health care professionals established to promote evidence-based research and education concerning the endocannabinoid system and therapeutic applications of endocannabinoid and cannabinoid agents.

We will do this by:

Educating: Researchers, health care practitioners and the public about the endocannabinoid system and possible roles of cannabinoids in clinical practice;

Facilitating: Research regarding the endocannabinoid system, mechanisms of action and clinical safety and efficacy of cannabinoids;

Creating: A networking forum for researchers investigating endocannabinoids and cannabinoids;

Advancing: Our understanding of the role of endocannabinoids and cannabinoids in health and disease.